Össur hf. provided earnings guidance for the year 2022. For the period, the company's organic sales growth is expected to be in the range of 6% to 9%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.8 DKK | -1.03% | -2.37% | +4.92% |
04-23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
04-23 | Embla Medical hf. Provides Earnings Guidance for the Year 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.92% | 1.8B | |
-11.50% | 21.14B | |
+4.15% | 17.59B | |
+9.03% | 14.06B | |
+9.19% | 10.13B | |
-11.30% | 2.28B | |
+34.04% | 1.65B | |
+24.42% | 652M | |
0.00% | 385M | |
+72.96% | 150M |
- Stock Market
- Equities
- EMBLA Stock
- News Embla Medical hf.
- Össur Hf. Provides Earnings Guidance for the Year 2022